Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · May 28, 2023

Budesonide/Formoterol Maintenance and Reliever Therapy vs Fluticasone/Salmeterol Fixed-Dose Treatment in Patients With COPD



Additional Info

Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD
Thorax 2023 May 01;78(5)451-458, S Muiser, K Imkamp, D Seigers, NJ Halbersma, JM Vonk, BHD Luijk, GJ Braunstahl, JW van den Berg, BJ Kroesen, JWH Kocks, IH Heijink, HK Reddel, HAM Kerstjens, M van den Berge

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading